Gazyva Approved By FDA for Follicular Lymphoma

The Food and Drug Administration has approved Gazyva plus bendamustine for the treatment of follicular lymphoma.

The approval is relevant to patients who have relapsed after or are unresponsive to the drug Rituxan, according to Gazyva's manufacturer Genentech.

"People with follicular lymphoma whose disease returns or worsens despite treatment with a Rituxan-containing regimen need more options because the disease becomes more difficult to treat each time it comes back," said Sandra Horning, Genentech's chief medical officer and head of Global Product Development.

In trials, researchers found that Gazyva plus bendamustine - followed by Gazyva alone - slowed disease progression by 52 percent compared with patients taking a Rituxan regimen or just bendamustine alone.

Follicular lymphoma treatment options

Follicular lymphoma (FL) is the most common type of non-Hodgkin lymphoma, and many people have no symptoms at the time they are diagnosed.

According to the Lymphoma Research Foundation, FL is generally responsive to radiation and chemotherapy, and rituximab and bendamustine are the most common drugs used to treat the condition.

Because the disease often returns, however, Gazyva's promise may represent hope for patients who aren't responsive to the more traditional treatment methods for FL.

"Gazyva plus bendamustine provides a new treatment option that can be used after relapse to significantly reduce the risk of progression or death," Horning said.

Source: CURE Today

Image courtesy of everydayplus/FreeDigitalPhotos.net

More Articles

More Articles

This entry looks at Non Hodgkin's Lymphoma in the lungs, clinically known as pulmonary lymphoma, one of the subtypes of lymphoma. 'Lymphoma' is an...

In order to prevent developing any subtype of lymphoma, it would be helpful to know the causes of lymphoma. Unfortunately, in virtually every case...

BEAM chemotherapy is an acronym representing a small family of combination chemotherapy regimens that are used chiefly as salvage regimens in the...

There are two types of cancer: benign and malignant. Benign cancers are the kind that don't spread and don't threaten one's life. Malignant...

The Erythrocyte Sedimentation Rate (ESR - sometimes called sed rate or sedimentation rate) is a nonspecific screening test for various...

Blood counts can be used to identify disease and monitor patient health during cancer treatments. Though these tests cannot diagnose lymphoma on...

MALT lymphoma is a rare B-cell non-Hodgkin's lymphoma that typically runs an indolent or slow-growing clinical...

Mantle cell lymphoma (MCL) is just one of 50-60 known B-cell subtypes of...

After some of the dust has settled, the thoughts of many new lymphoma patients turn to diet and nutrition. They want to know if, in the past,...

According to a study by Japanese researchers, the SMILE combination chemotherapy protocol is effective against extranodal natural killer/T-cell...

In a perfect world, every case of cancer would respond to, and be cured by first-line therapy. Unfortunately, it is not often the case. This is...

Patients treated with maintenance rituximab had three times longer progression-free survival. This is a summary of an article published in the...

Prednisone is a glucocorticosteroid (a steroid) used in the treatment of many types of cancers. It functions as an anti-inflammatory medicine that...

In 1964, researchers at the National Cancer Institute developed the first combination chemotherapy that cured a...

Since so many chemotherapy agents can affect a patient’s sex drive and fertility, thinking about these issues prior...